RxDoctor Payments Data

Eon Shin, MD

Hand Surgery · Philadelphia, PANPI 1841228608

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.1%), other and food and beverage — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Linvatec Corporation at 44.6% of the total. Reporting peaked in 2022 at $20,337 and has fallen 99.3% since, to $137 in 2025.

$43,878in general payments, 2019–2025

Across 69 payments — averaging $635.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$20K
  • Synthes USA Products LLC$12K
  • Integra Lifesciences Corporation$5K
  • In2bones USA, LLC$2K
  • Medical Device Business Services, Inc.$2K
  • Checkpoint Surgical, Inc$1K
  • plus $905 from 18 others

What the payments were for

  • Consulting fees$22,41351%
  • Speaking & faculty fees$6001%
  • Travel & lodging$2110%
  • Food & beverage$1,0922%
  • Other$19,56245%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,878 in reported general payments places this provider in the 85th percentile of 110 hand surgery providers in Pennsylvania.

See all hand surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$492,965
Medicare patients
778
Services billed
4,487

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl288$606
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim30$110
Tramadol Hcl15$18

Paid to pharmacies, not to this prescriber.

Other hand surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →